nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2C—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—E2F1—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—CDK2—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—RB1—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—E2F4—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2C—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—GNA11—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—CDKN1B—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—CDK2—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—E2F5—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—E2F4—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYBL2—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—GNAQ—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—E2F2—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—RBL1—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—RB1—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—CDKN1A—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—EP300—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—CDKN1B—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—RBL2—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—E2F5—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—HDAC1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYBL2—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—E2F4—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—E2F2—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RBL1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—E2F3—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—RBBP4—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—RB1—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDC25A—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND3—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—EP300—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—MYC—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TFDP1—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RBL2—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—CDKN1B—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PSPH—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—E2F3—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RBBP4—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND3—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—TP53—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDC25A—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—CDKN1A—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—MYC—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TFDP1—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSPH—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND3—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SAG—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—MYC—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDK6—ocular cancer	0.001	0.001	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000992	0.000992	CbGpPWpGaD
Trimethoprim—DHFR—Disease—E2F5—ocular cancer	0.000982	0.000982	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000977	0.000977	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000963	0.000963	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000963	0.000963	CbGpPWpGaD
Trimethoprim—DHFR—Disease—E2F4—ocular cancer	0.000962	0.000962	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00096	0.00096	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—MYC—ocular cancer	0.000944	0.000944	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RBL1—ocular cancer	0.000943	0.000943	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RPL39—ocular cancer	0.000943	0.000943	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000912	0.000912	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDK6—ocular cancer	0.000874	0.000874	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND2—ocular cancer	0.000861	0.000861	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—HDAC1—ocular cancer	0.000861	0.000861	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000796	0.000796	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000792	0.000792	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000788	0.000788	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2B—ocular cancer	0.000772	0.000772	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TFDP1—ocular cancer	0.00076	0.00076	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000753	0.000753	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND2—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—HDAC1—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000727	0.000727	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000722	0.000722	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—E2F1—ocular cancer	0.000708	0.000708	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000691	0.000691	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.000673	0.000673	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.000664	0.000664	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000646	0.000646	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—E2F1—ocular cancer	0.000618	0.000618	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDK2—ocular cancer	0.000611	0.000611	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAML2—ocular cancer	0.000604	0.000604	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000603	0.000603	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000601	0.000601	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDK4—ocular cancer	0.000577	0.000577	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000563	0.000563	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RB1—ocular cancer	0.000562	0.000562	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000552	0.000552	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDK2—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Trimethoprim—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDK4—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—RB1—ocular cancer	0.000502	0.000502	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.0005	0.0005	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000495	0.000495	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.00049	0.00049	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HDAC1—ocular cancer	0.000442	0.000442	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GNA11—ocular cancer	0.000441	0.000441	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000441	0.000441	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RB1—ocular cancer	0.000438	0.000438	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000437	0.000437	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSPH—ocular cancer	0.000433	0.000433	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MDM2—ocular cancer	0.000428	0.000428	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000418	0.000418	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000417	0.000417	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GNAQ—ocular cancer	0.00041	0.00041	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN2B—ocular cancer	0.000396	0.000396	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1B—ocular cancer	0.000391	0.000391	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GNA11—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—EP300—ocular cancer	0.000384	0.000384	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000381	0.000381	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00038	0.00038	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSPH—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000376	0.000376	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MDM2—ocular cancer	0.000374	0.000374	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1A—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GNAQ—ocular cancer	0.000358	0.000358	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSPH—ocular cancer	0.000353	0.000353	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—EP300—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1B—ocular cancer	0.000341	0.000341	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	0.000335	0.000335	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1A—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—EP300—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSPH—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MDM2—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1A—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EP300—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GNA11—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNA11—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNA11—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNAQ—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—ocular cancer	8.91e-05	8.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.33e-05	8.33e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—ocular cancer	7.78e-05	7.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNA11—ocular cancer	7.32e-05	7.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNAQ—ocular cancer	6.81e-05	6.81e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—ocular cancer	4.56e-05	4.56e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—ocular cancer	3.97e-05	3.97e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—ocular cancer	3.71e-05	3.71e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—ocular cancer	2.75e-05	2.75e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—ocular cancer	2.45e-05	2.45e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—ocular cancer	2.4e-05	2.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—ocular cancer	2.24e-05	2.24e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—ocular cancer	1.48e-05	1.48e-05	CbGpPWpGaD
